Free Trial

Passage Bio (PASG) SEC Filings & 10K Form

Passage Bio logo
$0.33 +0.00 (+0.30%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.33 0.00 (-0.30%)
As of 04/17/2025 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Passage Bio SEC Filings

DateFilerForm TypeView
04/17/2025
5:10 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
6:00 AM
Passage Bio (Filer)
Form DEF 14A
04/16/2025
6:01 AM
Passage Bio (Filer)
Form DEFA14A
04/16/2025
6:02 AM
Passage Bio (Filer)
Form ARS
04/15/2025
4:40 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2025
6:15 AM
Passage Bio (Filer)
Form PRE 14A
03/18/2025
4:11 PM
Cale Edgar B. (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:11 PM
Chou William (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:12 PM
Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:05 AM
Passage Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2025
5:09 AM
Passage Bio (Filer)
Form 424B5
03/04/2025
6:15 AM
Passage Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:01 AM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:21 PM
Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:17 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:09 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:34 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:31 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
12/11/2024
4:32 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
6:07 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:11 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:21 PM
Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13G/A
11/13/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
3:41 PM
Cale Edgar B. (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:51 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
5:38 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:36 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
7:38 PM
ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:15 PM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:06 PM
Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
08/09/2024
4:11 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
4:15 PM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SC 13G/A
08/08/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Claim Your FREE Protection Guide (Ad)

In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...

Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now →
08/01/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:01 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
3:35 PM
Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
05/23/2024
4:43 PM
Countouriotis Athena (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:51 PM
Passage Bio (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:52 PM
Passage Bio (Issuer)
Sondhi Dolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:53 PM
Islam Saqib (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:55 PM
Kapadia Sandip (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:56 PM
GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:15 AM
Passage Bio (Filer)
Form 424B3
05/14/2024
6:01 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PASG) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners